Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder

NCT00836069 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Pfizer has terminated the execution of this protocol

Conditions

Anxiety Disorders

Interventions

DRUG: No drug name provided by Sponsor; drug referenced as PD 0332334
DRUG: Paroxetine
DRUG: Placebo

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]